Abstract. The present study successfully demonstrated the neuroprotective effects of purified Lycium barbarum polysaccharide (LBPS02) against glutamate (L-Glu)-induced differentiated PC12 (DPC12) cell apoptosis. Purified polysaccharide was obtained by using a diethylaminoethyl-52 cellulose anion exchange column and a Sepharose G-100 column. During identification and characterization, LBPS02 was validated to be a fraction with 68 kDa molecular weight, and with a structure containing 1→3, 1→4 and 1→6 linkages. Data further revealed that LBPS02 pretreatment effectively improved cell viability, reduced apoptosis rate, and restored the mitochondrial dysfunction in L-Glu-exposed cells. LBPS02 suppressed L-Glu-induced reactive oxygen species (ROS accumulation in DPC12 cells. N-acetylcysteine, a ROS inhibitor, strongly enhanced the efficacy of LBPS02. Furthermore, LBPS02 normalized the levels of anti-apoptotic proteins, and regulated the phosphorylation of extracellular signal-regulated kinases (ERKs) and protein kinase B (Akt) in L-Glu-explored DPC12 cells. In conclusion, LBPS02-mediated neuroprotective effects are at least partially associated with the modulation of Akt and ERKs, and the subsequent inhibition of the mitochondrial apoptotic pathway. LBPS02 may be a candidate for neurodegenerative disease treatment.
Introduction
Neurodegenerative disorders have received research attention due to their devastating nature and unsuccessful therapies. Although the etiology of these diseases remains unknown, oxidative damage, mitochondrial dysfunction and protein aggregation are reported as common pathological features of neurological disorders (1, 2) . In the brain, glutamate (L-Glu) acts as a fast excitatory neurotransmitter in the central nervous system, and is responsible for two major intracellular toxicity pathways (3, 4) . Excessive accumulation of L-Glu leads to the collapse of mitochondrial membrane potential (MMP), which is initiated by B-cell lymphoma 2 (Bcl-2) family members including the pro-and anti-apoptotic proteins. As reported previously, L-Glu-induced cell apoptosis is associated with the activation of extracellular signal-regulated kinases (ERKs) and protein kinase B (Akt) (5) . Akt is involved in regulating oxidative stress in neuronal cells, and ERKs participates in mitochondria-mediated apoptotic cell death (6) .
Herbal medicines, including Ginseng radix and Polygalae radix, are reported to exhibit broad protective properties in various neurodegenerative diseases (7, 8) . Currently, the acquisition of bioactive ingredient from herbs has become an important study focus. Purified polysaccharides from the flowers of Nerium indicum exhibit protective activities against β-amyloid (Aβ) peptides in cortical neurons (8) . A 75-kDa polysaccharides purified from Sparassis crispa has neuroprotective effects against L-Glu-induced cell damage via the mitochondria-associated apoptotic pathway (9) . Based on previous conclusions, the chemical composition, glycosidic linkages and degree of branching are responsible for the bioactivities of polysaccharides (10) .
As a medicinal plant, Lycium barbarum has been widely used in southeast Asia. The immunoregulatory, neuroprotective and antifatigue effects of L. barbarum have been widely reported by previous studies (11) (12) (13) . L. barbarum polysaccharide (LBPS) prevents 6-hydroxydopamine-induced PC12 cell apoptosis partially via effects on the reactive oxygen species (ROS)-nitric oxide (NO) pathway (14) . L. barbarum polysaccharides prevent damage to retinal ganglion cells from acute ocular hypertension-induced ischemic injury (15) . These encouraging data prompted further investigation of the neuroprotective effects of purified polysaccharides from L. barbarum and the potential underlying mechanisms.
In the present study, functional polysaccharides of L. barbarum were purified and characterized. In L-Glu-induced apoptotic differentiated rat pheochromocytoma (DPC12) cells, the protective effects of the purified polysaccharides were investigated. Cell viability, apoptotic rate, mitochondrial function and the expression of associated proteins were detected to determine whether purified polysaccharides from L. barbarum were neuroprotective against L-Glu-induced toxicity in DPC12 cells.
Materials and methods
Polysaccharide purif ication and characterization. Purification of L. barbarum polysaccharides. L. barbarum (obtained from Ningxia province, China) was extracted with water (100 g L. barbarum in 500 ml) twice at 80˚C for 3 h. The collected supernatant was concentrated at 37˚C and 4,000 x g for 10 min and proteins were removed using 50 ml Sevag reagent (n-butanol: chloroform, 1:4 vol). The polysaccharides were purified according to previous methods (16) . Following precipitation with 4-fold ethanol at 4˚C for 12 h, the precipitate was dissolved in double distilled water and subjected to a diethylaminoethyl (DEAE)-52 cellulose anion exchange column (2.6 cm x 35 cm; Whatman; GE Healthcare Life Sciences, Little Chalfont, UK) and a gel permeation chromatography system (Sepharose G-100; Pharmacia; GE Healthcare Life Sciences). The fraction was collected, detected, freeze-dried and designated LBPS02 (Fig. 1A) .
Molecular weight measurement. The methodology was similar to previous studies (9 .
Monosaccharides analysis. Similar to previous studies (9), 20 mg LBPS02 was hydrolyzed with 1 M H 2 SO 4 (1 ml) at 105˚C for 6 h in a sealed glass tube. Following ~pH adjustment to 7.0 and centrifugation at 4,000 x g for 10 min, the hydrolysates were analyzed using the HPLC/ELSD system. D-glucose, D-galactose, D-mannose, D-xylose, L-rhamnose and L-arabinose were used as monosaccharide standards (Sigma-Aldrich; Merck KGaA).
Periodate oxidation-Smith degradation reaction of LBPS02.
Similar to previous studies (17), 20 mg of LBPS02 was dissolved in 15 mM NaIO 4 (25 ml; pH 4) at 4˚C in darkness. Cell viability analysis. DPC12 cells (2x10 4 cells) were seeded into 96-well plates, then treated with LBPS02 at doses of 10 and 30 µg/ml alone for 24 h, or pretreated with LBPS02 for 3 h prior to incubation with 20 mM L-Glu for another 24 h. In a separate experiment, cells were exposed to 1 mM of N-Acetyl-L-cysteine (NAC; S0077; Beyotime Institute of Biotechnology, Haimen, China) a ROS inhibitor for 30 min, followed by a 3-h incubation with 30 µg/ml LBPS02, and then treated with 20 mM L-Glu for another 24 h. Treated cells were then incubated with 0.5 mg/ml 3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT; Sigma-Aldrich; Merck KGaA) for 4 h at 37˚C in darkness. Following addition of dimethyl sulfoxide (DMSO; 100 µl), a microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA) was used to measure the absorbance at a wavelength of 540 nm.
Cell apoptosis analysis. DPC12 cells (1x10 5 ) were pretreated with 10 and 30 µg/ml for 3 h, and then co-incubated with 20 mM L-Glu for another 24 h. Cells were harvested and incubated with 5 µl Annexin V-fluorescein isothiocyanate (20 µg/ml) and 5 µl propidium iodide (PI; 50 µg/ml; BD Biosciences, Franklin Lakes, NJ, USA) for 20 min in darkness at room temperature. Cell apoptosis was analyzed using flow cytometry (FC500; Beckman Coulter, Inc., Brea, CA, USA).
Measurement of ROS concentration and caspase-3 activition.
DPC12 cells (1x10 5 ) were pretreated with 10 and 30 µg/ml LBPS02 for 3 h, and then co-incubated with 20 mM L-Glu for 24 h. Treated cells were harvested and lysed using radioimmunoprecipitation assay (RIPA) buffer (Sigma-Aldrich; Merck KGaA). Following detection of protein concentration using BCA Protein Assay kit, the intracellular ROS levels (Reactive oxygen species Assay kit) and caspase-3 activation (Caspase-3 activity assay kit) were determined according to protocols of commercial kits purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China).
The intracellular ROS levels were also determined by flow cytometry. Treated cells were harvested and incubated with 10 µM dichloro-dihydro-fluorescein diacetate at 37˚C for 10 min in darkness. After three washes with phosphate-buffered saline, the changes of intracellular ROS level were analyzed by flow cytometry (FC500; Beckman Coulter, Inc.). Western blot analysis. DPC12 cells (1x10 5 ) were pretreated with 10 and 30 µg/ml LBPS02 for 3 h, and then co-incubated with 20 mM L-Glu for another 24 h. In another experiment, DPC12 cells were treated with 10 and 30 µg/ml LBPS02 alone, 20 mM L-Glu alone or pretreated with 10 and 30 µg/ml LBPS02 for 3 h, and then co-exposed to L-Glu. After incubation for 30-240 min, cells were harvested and lysed by RIPA buffer contained with 1% protease inhibitor cocktail (Sigma-Aldrich; Merck KGaA). Following detection of protein concentration via the Coomassie Brilliant Blue method, 30 µg proteins were separated by 10-12% SDS-PAGE and transferred electrophoretically onto nitrocellulose membranes (0.22 µm; Bio Basic, Inc., Markham, ON, Canada). The transferred membranes were blocked in 5% bull serum albumin (BSA) at room temperature for 4 h, and then the membranes were incubated with the following primary antibodies at 1:1,000 dilution overnight at 4˚C: total (t)-Akt (ab108266), phosphor (p)-Akt (ab18206), t-ERKs (ab36991), p-ERKs (ab201015), Bcl-2 (ab321224), Bcl-2 associated X apoptosis regulator (Bax) (ab32503), cleaved caspase-3 (ab49822), caspase-3 (ab13847) and GAPDH (ab8245; all Abcam, Cambridge, UK), followed by incubation with horseradish peroxidase-conjugated secondary antibodies (SC2005; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) using 2% BSA at dilution of 1:2,000 at 4˚C for 4 h. Enhanced chemiluminescence detection kits (GE Healthcare Life Sciences, Little Chalfont, UK) were applied for chemiluminescence, and the band intensity was quantified by scanning densitometry via ImageJ version 1.38x (National Institutes of Health).
Measurement of MMP. DPC12 cells (2x10
Statistical analysis. Data are expressed as mean ± standard deviation, and evaluated by a one-way analysis of variance followed by Dunn's test using SPSS software version 16.0 (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indictae a statistically significant difference.
Results

Purification and characterization of LBPS02.
Following purification by a DEAE-cellulose column and a Sepharose G-100 gel permeation chromatography system, LBPS02 was obtained (Fig. 1A and B) . As detected via HPLC, the molecular weight of LBPS02 demonstrated to be 68 kDa. No absorbance peak was detected at the wavelength of 260 or 280 nm in the UV spectra indicating the lack of nuclear acid and protein contamination in LBPS02 (Fig. 1C) . Furthermore, according to the FTIR spectra, hydroxyl (3,450 cm ) were present in LBPS02 (Fig. 1D) . Periodate oxidation-Smith degradation is widely used to analyze the linkages of glucose in purified polysaccharides ( Fig. 1E and F) . The consumption of sodium periodate of LBPS02 is presented in Fig. 1E . Following analysis of LBPS02 hydrolysates via HPLC, L-rhamnose monohydrate, glucose, glycerol and erythritol were detected (Fig. 1F) .
LBPS02 protects DPC12 cells against L-Glu induced cell
damage. LBPS02 alone exerted no effect on DPC12 cell viability; however, 3-h pretreatment with LBPS02 improved cell viability 19.1% in L-Glu-exposed DPC12 cells compared with those treated with L-Glu only (P<0.05; Fig. 2A ). LBPS02 at doses of 10 and 30 µg/ml reduced caspase-3 activation by ~24.6 and 33.9%, respectively, in L-Glu-induced cells (P<0.05; Fig. 2B ). LBPS02 strongly restored the apoptosis rate in L-Glu-exposed DPC12 cells (P<0.01; Fig. 2C ). An accumulation of intracellular ROS was observed following L-Glu treatment; LBPS02 strongly suppressed intracellular ROS levels induced by L-Glu, as measured by flow cytometry (Fig. 2D) and reagent color-developing method of a ROS detection kit (P<0.01; Fig. 2E ). Furthermore, the protective effect of LBPS02 against cytotoxicity was strongly enhanced by 30 min pretreatment with 1 mM NAC, a ROS inhibitor (75.7±2.5% vs. 88.7±3.7%; P<0.05; Fig. 2F ).
LBPS02 improved mitochondrial function. MMP is responsible for intrinsic and extrinsic apoptosis. As indicated by the enhanced red fluorescence intensity, LBPS02 restored depolarization of MMP in L-Glu-treated cells (Fig. 3A) . Additionally, a significant reduction on Bcl-2 expression, and enhancement of Bax and cleaved caspase 3 were observed in L-Glu-treated DPC12 cells (P<0.05; Fig. 3B ). LBPS02 pre-treatment at 30 µg/ml resulted in a 19.1% enhancement on Bcl-2 level, and 21.7 and 25.2% suppression on Bax and cleaved caspase-3 expressions, respectively, compared with cells treated with L-Glu only (P<0.01; Fig. 3B ). LBPS02 also influenced the expressions of total caspase 3 (Fig. 3B) . 
Discussion
The chemical structures of polysaccharides are responsible for their bioactivities. LBPS02, purified from L. barbarum, was systemically identified and characterized in the present study. No absorbance at wavelength of 260 and 280 nm was observed in UV spectrum confirming that the lack of nuclear acid and proteins within the LBPS02 extract. As revealed by the FTIR spectrum, the C-H, C=O, C-O-C and C-O-H structures were confirmed to be present in LBPS02. In periodate oxidation-Smith degradation analysis, 1→ and/or 1→6 linkages may exist within LBPS02, indicated by the low production of formic acid. The presence of 1→3 linkages within LBPS02 is confirmed by the consumption of <1 mol periodate. In permanganate oxidation, the observation of erythritol in hydrolysates indicates the presence of 1→4 linkages. Further information on the skeleton structure of LBPS02 will be analyzed by combining the present results with the results of nuclear magnetic resonance.
The current study successfully confirmed the neuroprotective effects of LBPS02 by observing its regulatory activities on cell viability, apoptosis rate, ROS accumulation, MMP and apoptosis-associated protein expressions in DPC12 cells. The data reveal that LBPS02-mediated neuroprotection may involve the mitochondria-associated apoptotic pathway.
Central nervous system stress may cause high levels of L-Glu, which leads to cell damage (18) . L-Glu-induced cell apoptosis may be initiated by mitochondrial dysfunction. The accumulation of ROS is causes the opening of mitochondrial permeability transition pore, which further induces mitochondria apoptosis (19) . There is a positive feedback loop between intracellular ROS and mitochondria (20) . In the present study, NAC, a ROS inhibitor, significantly enhanced LBPS02-mediated neuroprotection, which confirmed the roles of ROS. Furthermore, LBPS02 suppressed the levels of cleaved caspase-3 and Bax, and enhanced the expression of Bcl-2 in L-Glu-exposed cells. The ratio of Bcl-2 and Bax serves as an index of mitochondria-associated cell apoptosis (21) . The caspase family has a central role in neurodegeneration, and activated caspase-3 may translocate into nucleus to regulate nuclear substrates associated with apoptosis (22) . The disruption of MMP induces activation of the enzymatic apoptotic machinery of caspases, particularly caspase-3. The present data indicate that LBPS02 mediates neuroprotection against L-Glu-induced DPC12 cell damage via effects on caspase-dependent mitochondrial signaling.
ERKs and Akt are associated with cell proliferation and survival. The inhibition of ERKs phosphorylation leads to suppressed Bcl-2 and Bcl-xL expressions (23) , which may influence mitochondrial function. It has been previously demonstrated that L-Glu strongly suppressed the levels of ERKs phosphorylation in DPC12 cells (5) . Furthermore, the activation of Akt is reported to inhibit the expression of pro-apoptotic proteins, including Bcl-2 family proteins (24) , which may further regulate mitochondrial function. Bone marrow mesenchymal stem cell-derived microvesicles protect PC12 cells against L-Glu-induced excitotoxicity by increasing Akt phosphorylation and Bcl-2 expression (25) . The isomers albiflorin and paeoniflorin exhibit neuroprotective effects against L-Glu-induced toxicity in PC12 cells, with their effects associated with the modulation of Akt activities (26) . Taking these results together, it is proposed that the neuroprotective effects of LBPS02 are at least partially associated with the restoration of Akt and ERKs, and the subsequent inhibition of the mitochondrial apoptotic pathway.
There are certain limitations in the present study. Initially, although the effects of LBPS02 on mitochondrial function, ROS accumulation, and the activation of Akt and ERKs were observed, the association among them requires further investigation. Additionally, based solely on the results of the present study, the relationship between the structure of LBPS02 and its bioactivity is difficult to identify. All these limitations will be investigated in further studies investigating L. barbarum.
In conclusion, LBPS02 was successfully purified from L. barbarum, and exhibits protective effects against L-Glu-induced DPC12 cell apoptosis. Further experiments reveal that the mitochondria-associated pathway has a central role during this effect. Purified polysaccharides from L. barbarum may be a potential candidate for neurodegenerative disease therapy.
